Steward Partners Investment Advisory’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Steward Partners Investment Advisory’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,150	Closed	-$19K	–	2795
2018 Q2	$19K	Buy	+2,150	New	+$19.3K	﹤0.01%	1499

Steward Partners Investment Advisory's JNP Position: Q3 2018 in Review

Steward Partners Investment Advisory sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 2,150 shares — an estimated $19K sold.

Steward Partners Investment Advisory first reported a position in JNP in Q2 2018 and held it in 1 quarter. The position peaked at $19K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Steward Partners Investment Advisory reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Steward Partners Investment Advisory sold 2,150 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $19K.
Steward Partners Investment Advisory first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
Steward Partners Investment Advisory's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $19K in Q2 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2018, filed 23 Oct 2018.